Literature DB >> 9563573

Oral manifestations of HIV infection in 600 South African patients.

T M Arendorf1, B Bredekamp, C A Cloete, G Sauer.   

Abstract

Oral lesions associated with HIV infection, as classified by the EC-Clearinghouse on Oral Problems related to HIV infection and the WHO Collaborating Centre on Oral manifestations of the immunodeficiency virus, were studied in 600 consecutive HIV-infected patients in Cape Town, South Africa. One or more lesions were seen in 60.4% of cases. Combined candidal lesions were evident in 37.8%, hairy leukoplakia in 19.7% and combined gingival/periodontal lesions in 8.5% of patients seen. Lesions less commonly recorded include oral ulceration (2.9%) and Kaposi's sarcoma (1.5%). The clinical range of lesions seen is similar to those reported elsewhere, but socio-cultural differences allowed no reliable comparison. More than a quarter of our patients had oral soft tissue discomfort necessitating treatment; in 3.3% these were the presenting symptom. This indicates a potential major public health concern requiring education in recognition and appropriate referral and management.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Biology; Cross Sectional Analysis; Developing Countries; Diseases; English Speaking Africa; Hiv Infections; Measurement; Oral Effects; Physiology; Prevalence; Research Methodology; Research Report; Signs And Symptoms; South Africa; Southern Africa; Viral Diseases

Mesh:

Year:  1998        PMID: 9563573     DOI: 10.1111/j.1600-0714.1998.tb01936.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  23 in total

Review 1.  Incorporating salivary biomarkers into nursing research: an overview and review of best practices.

Authors:  Douglas A Granger; Sara B Johnson; Sarah L Szanton; Dorothée Out; Lynette Lau Schumann
Journal:  Biol Res Nurs       Date:  2012-05-15       Impact factor: 2.522

2.  Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253.

Authors:  C H Shiboski; H Chen; M A Ghannoum; L Komarow; S Evans; P K Mukherjee; N Isham; D Katzenstein; A Asmelash; A E Omozoarhe; S Gengiah; R Allen; S Tripathy; S Swindells
Journal:  Int J Tuberc Lung Dis       Date:  2014-06       Impact factor: 2.373

3.  Effects of long-term use of HAART on oral health status of HIV-infected subjects.

Authors:  Wipawee Nittayananta; Sineepat Talungchit; Sutep Jaruratanasirikul; Kachornsakdi Silpapojakul; Panthip Chayakul; Ampaipith Nilmanat; Nannapat Pruphetkaew
Journal:  J Oral Pathol Med       Date:  2010-02-22       Impact factor: 4.253

4.  Effects of two different growth media on the postantifungal effect induced by polyenes on Candida species.

Authors:  M Shu; A N Ellepola; L P Samaranayake
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

5.  Perinatal HIV Infection and Exposure and Their Association With Dental Caries in Nigerian Children.

Authors:  Modupe Coker; Samer S El-Kamary; Cyril Enwonwu; William Blattner; Patricia Langenberg; Emmanuel Mongodin; Paul Akhigbe; Ozo Obuekwe; Austin Omoigberale; Manhattan Charurat
Journal:  Pediatr Infect Dis J       Date:  2018-01       Impact factor: 2.129

6.  The impact of polyene, azole, and DNA analogue antimycotics on the cell surface hydrophobicity of Candida albicans and Candida tropicalis in HIV infection.

Authors:  S Anil; A N B Ellepola; L P Samaranayake
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

7.  Oral manifestations of HIV/AIDS in clients attending TASO clinics in Uganda.

Authors:  J F Tirwomwe; C M Rwenyonyi; L M Muwazi; B Besigye; F Mboli
Journal:  Clin Oral Investig       Date:  2007-05-03       Impact factor: 3.573

8.  Racial distribution of Candida dubliniensis colonization among South Africans.

Authors:  Elaine Blignaut; Claude Pujol; Sophie Joly; David R Soll
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.

Authors:  Pranab K Mukherjee; Huichao Chen; Lauren L Patton; Scott Evans; Anthony Lee; Johnstone Kumwenda; James Hakim; Gaerolwe Masheto; Frederick Sawe; Mai T Pho; Kenneth A Freedberg; Caroline H Shiboski; Mahmoud A Ghannoum; Robert A Salata
Journal:  AIDS       Date:  2017-01-02       Impact factor: 4.177

10.  Preparation, in vitro characterization and preliminary in vivo evaluation of buccal polymeric films containing chlorhexidine.

Authors:  Claudia Juliano; Massimo Cossu; Paola Pigozzi; Giovanna Rassu; Paolo Giunchedi
Journal:  AAPS PharmSciTech       Date:  2008-11-19       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.